BC
BSX icon

Burleson & Co’s Boston Scientific BSX Stock Holding History

Burleson & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.04K Hold
44
– – ﹤0.01% 337
2022
Q3 		$2K Hold
44
– – ﹤0.01% 343
2022
Q2 		$2K Hold
44
– – ﹤0.01% 335
2022
Q1 		$2K Buy
+44
New +$1.91K ﹤0.01% 327

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Burleson & Co's BSX Position: Q4 2022 in Review

Burleson & Co held its Boston Scientific (BSX) position steady in Q4 2022 at 44 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Burleson & Co first reported a position in BSX in Q1 2022 and has held it in 4 quarters since. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Burleson & Co held 44 shares of Boston Scientific worth $2.04K as of Q4 2022.
  • Burleson & Co left its Boston Scientific share count unchanged in Q4 2022.
  • Boston Scientific made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #337 holding.
  • Burleson & Co first reported a position in Boston Scientific in Q1 2022 and has held it in 4 quarters since.
  • 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.